Marijuana Expert Witnesses in Connecticut

This expert has over 30 years of experience in law enforcement with 20 of those years in the Drug Enforcement Administration. At the DEA, he worked in various positions including Resident Agent in Charge and Inspector. He currently owns a consulting & investigative services firm and works as a Private Investigator specializing in Consulting and Private and Executive Securities.

This highly qualified Professor of Pharmaceutical Sciences received a bachelors in Pharmacy and a PharmD in Clinical Pharmacy. He is a member of numerous highly regarded professional organizations including the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology. He is an innovator with 10 patents registered in his name. He is widely published in Pharmaceutical literature with over 350 articles. In addition to his academic role he currently serves as CEO of three Pharmaceutical companies.

This expert began his career as a medical consultant to the emergency room drug treatment and referral program. He’s been practicing for over 40 years and focuses on internal medicine, consulting in clinical pharmacology, and quality assurance medicine. He is currently involved in many aspects of pharmacology, and holds many positions on boards and committees related to drug abuse, prevention, and treatment. He has been a special government employee consultant for the US Department of Health and Human Services, Public Health Service Food and Drug Administration, and Center for Drug Evaluation. He has numerous patents, trademarks, fellowships, grants, and publication and presentations.

This highly qualified expert has been conducting academic studies in toxicology for 30+ years. He completed his postdoctoral and fellowship training at Rochester University. He is a fellow at the American Association for the Advancement of the Sciences and a member of numerous professional associations, including the Academy of Toxicological Sciences, where he serves in the board of directors. He is also the past president of the International Neurotoxicology Association. He has authored approximately 300 peer-reviewed manuscripts and chapters in the area of neurotoxicology and serves on the editorial board of several journals. He is the former director of clinical pharmacology and toxicology at Vanderbilt and the former director of the NIEHS Molecular Toxicology Center. Currently, he is a professor and chair of molecular pharmacology at a major university in New York.

This expert is a well respected and established Professor of Law specializing in ethics of the healthcare industry. He has testified before Congress and state legislatures and served on government commissions and advisory boards, including the Food and Drug Administration. He has provided training on conflicts of interest related to pharmaceutical good governance for various nations under the aegis of the World Health Organization. He has participated in meetings of the National Academy of Sciences, Institute of Medicine and worked for the World Health Organization. He has extensive experience in the fields of health law and policy, pharmaceutical policy, biomedical law, medical ethics, and more.

This highly-qualified expert has extensive experience with pharmaceutical formulation development, as well as transdermal, topical, and controlled release drug delivery. He earned his BS in pharmaceutical science from Sandar Patel University before earning his MS and PhD in pharmaceutical science from Long Island University. This expert is active in his field as a member of the American Association of Pharmaceutical Scientists and holds a patent related to transdermal drug delivery. He formerly held roles in formulation development at Lincoln Pharmaceutical, Torrent Pharmaceuticals, and Apex Pharmaceuticals, and served as an assistant research scientist at Transdermal Research Pharm Laboratories. This expert is currently a principal scientist at a pharmaceutical laboratory in New York.

This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.

This highly-qualified expert in chemistry and pharmaceuticals has 20 years of experience in his field. He has experience with analytical chemistry analysis, formulation chemistry, and FDA regulation, and his work has involved in all aspects of drug research and development from synthesis/purification, in-vitro, in-vivo (efficacy, pharmacokinetics and pharmacodynamics) testing, dosing routs, drug formulation, stability studies and the management of CROs. He earned his BA in chemistry from Rhode Island College before earning his PhD in chemistry from Brown University. He formerly served as a scientist at Eikos Inc and as the principal scientist and project coordinator at Paratek Pharmaceuticals. He then worked as a consultant in pharmaceutical development for H-3 Biomedicine and Cemotics. Currently, this expert is a professor of chemistry at a college and a pharmaceutical advisor at a consultancy in Rhode Island.

This expert has over 45 years of experience in the field of alcohol research, alcohol industry standards, and drinking behavior. He earned his BA in anthropology and forestry from the University of Montana before earning both his MA and PhD in cultural anthropology from SUNY Buffalo. He also completed a postdoctoral fellowship in biomedical research at the University of North Carolina Medical School and is a member of the New York State Council on Problem Gambling. This expert is active in research in his field, having authored several peer-reviewed scientific articles and two books, as well as served internationally as a lecturer on alcohol-related topics. He previously served as the director of alcohol & drug abuse programming at the University of Minnesota, as the founder & associate director of the Center for Addiction Studies, and as the director of alcohol & drug prevention at SUNY System Administration. This expert is currently an independent drinking, gambling, and smoking consultant in New York.

This highly-qualified expert has over 30 years of experience in pharmacology. He earned his BS in pharmacy from Albany College of Pharmacy before earning his PhD from Shenandoah University. He is a board-certified pharmacotherapy specialist and a licensed pharmacist. He also holds a certification in pediatric advanced life support. He is active in his field as an author of several scientific articles and as a member of several organizations, including the American Society of Health-System Pharmacists and the Pediatric Pharmacy Advocacy Group. He has formerly served as a pharmacist for Brooks Pharmacy, the Medical University of South Carolina, Mary Imogene Bassett Hospital, and Griffin Hospital. He also served as the director of pharmacy for Option Care (Infucor), a clinical pharmacy specialist at Yale-New Haven Hospital, and the director of pharmacy at Upstate University Hospital. Currently, this expert is the executive director of pharmacy services at a university-affiliated hospital in New York.